Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), kills vultures (Gyps spp.) that consume tainted carcasses. As a result, vulture populations in India, Nepal, and Pakistan have been devastated. Studies on meloxicam and ketoprofen demonstrated that the toxicity of the NSAIDs is unpredictable, thereby necessitating individual testing of all available NSAIDs. Because it is no longer practical to use vultures for toxicity testing, we evaluated the Pied Crow (Corvus albus) as a model. Pied Crows (n56) were exposed to a dose of 0.8 and 10 mg/kg of diclofenac, with no signs of toxicity, and a rapid half-life of elimination. Using primary renal cell and hepatocyte cultures, a high tolerance was demonstrated at the cellular level. Meta-analysis of pharmacokinetic data for the Domestic Chicken (Gallus gallus) and the African White-backed (Gyps africanus), Cape Griffon (Gyps coprotheres), and Turkey Vultures (Cathartes aura) showed a trend toward toxicity when the half-life of elimination increased. We conclude that the crow is not susceptible to diclofenac and, more important, that toxicity in the Gyps species is probably related to zero-order metabolism.
INTRODUCTION
The Gyps spp. vulture populations on the Indian subcontinent have been devastated during the past 10-15 yr following their exposure to residues of diclofenac in the carrion they eat (Oaks et al., 2004; Prakash et al., 2007) . Although this exposure was accidental, the effect was unprecedented and resulted in global species declines nearing 99.9% . Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) often used in cattle on the Indian subcontinent because of its anti-inflammatory action, analgesic properties, low cost, and widespread availability (Swan et al., 2006b) . Diclofenac became the regional NSAID of choice, and large numbers of animals received the drug before death; because the Indian cow is sacred in Hindu religion, it often dies naturally rather than being slaughtered for meat at a young age. In addition, open disposal of livestock is practiced and scavengers, including vultures have year-round widespread access to carrion now known to contain high levels of diclofenac and other NSAID residues .
Although the cause of the Gyps vulture population decline has been conclusively linked to the widespread use and toxicity of diclofenac, the potential toxicity of other NSAIDs to scavengers is in question, especially because studies also show ketoprofen to be toxic (Naidoo et al., 2010a, b) . Although it is important to determine the safety of these drugs in Gyps spp. vultures to protect the remaining populations on the Indian subcontinent, it is equally important to recognize risks to worldwide populations of various species of vultures and other avian scavengers. The latter group of birds is probably equally at risk of accidental toxicity as many countries (Namibia, Spain, India, Italy, Israel) have introduced ''vulture restaurants,'' where colonies are artificially fed through routine placement of carcasses (Meretsky and Mannan 1999; Bamford et al., 2007; Gilbert et al., 2007; Cortes-Avizanda et al., 2009; Gustin et al., 2009; Margalida et al., 2009) . Hence, if any other NSAIDs (e.g., carprofen, flunixin meglumine, phenylbutazone, tolfenamic acid, meclofenamic acid, and ibuprofen) were to prove as toxic as diclofenac and ketoprofen, these vulture populations might also be at risk.
The optimal way to conclusively determine whether other NSAIDs are safe is to investigate their in vivo toxicity. Although this is theoretically possible using captive vultures, there are a large number of NSAIDs available, many of which may also be administered in combinations. Because most vulture species, including Gyps spp., are now regionally or globally endangered (IUCN, 2010) , in vivo trials on all drugs or combinations are not feasible, especially given the large sample sizes required to prove drugs to be safe (as was the case for meloxicam; Swan et al., 2006a) . One alternative would be to use a bird species that is common, widely distributed, easy to handle, and not endangered. Such a species would ideally be as susceptible to all NSAIDs to be tested as are Gyps species. The Domestic Chicken was initially considered because it is easily available, inexpensive, and sufficiently small to handle easily. However, Naidoo et al. (2007) found that the chicken was not sufficiently susceptible to the toxic effects of diclofenac to be a suitable surrogate. The diclofenac 50% lethal dose (LD 50 ) for chickens was approximately 10 mg/kg, and the drug had a rapid half-life of elimination of ,4 hr at a dose of 0.8 mg/kg. In comparison, in Gyps spp., the LD 50 is estimated at 0.098-0.23 mg/kg, and the corresponding halflife is .12 hr (Naidoo et al., 2007) .
Although still unproven, the different toxicity effects between chickens and Gyps spp. vultures may be related to different liver and kidney functions between the species. Vultures tend to be exposed to higher levels of uric acid because they consume a meat-based diet, whereas the diet of chickens is omnivorous. Therefore, vultures may be more sensitive to diclofenac because they cannot tolerate its uricosuric effects (Maier et al., 1979) . Alternatively, differences may be due to the metabolic capacity of the chicken liver, in which the diclofenac halflife is much shorter, and therefore, the metabolic processing appears to be much more efficient (Naidoo et al., 2007) . To eliminate one of these potential factors, we selected crows (Corvus spp.), which are more closely related to Old World Vultures and have similar scavenging behavior. In addition to being wild (rather than domesticated like the chicken), crows are also carrion eaters that, like vultures, generate high concentrations of uric acid daily. Our aim was to determine the sensitivity of wild-caught crows to the effects of diclofenac. We used Pied Crows (Corvus albus) because they are abundant and not threatened or endangered in Southern Africa.
MATERIALS AND METHODS

In vivo toxicity assay
Animal husbandry: The study was approved by the animal use and care committee of the University of Pretoria and followed ethical guidelines for the use of animals in South Africa. Twelve Pied Crows were captured using a baited cage. The birds were transported to the Poultry Reference Laboratory (Onderstepoort, South Africa) and housed in individual layer cages. Birds were identified using colored leg bands. Animals were given approximately 60 g of minced beef per day. The meat was assumed free of diclofenac and other NSAIDs because South Africa follows the CODEX ALIMENTARIUS standards in controlling drug residues in food destined for human consumption. Birds had free access to water throughout the study.
Animal treatment: Birds were dosed using a two-way crossover design. For the first phase, birds were dosed with diclofenac (Adco Diclofenac, Adcock Ingram, Johannesburg, South Africa) at 0.8 mg/kg (n56) or with sterile water (n56) by gavage. Following a 2-wk wash-out period, the groups were swapped (crossed), and the birds dosed again with either sterile water (n56) or diclofenac at 10 mg/kg (n56). To continue into the second phase of the study, a prerequisite was that there be no signs of toxicity (either clinically or in any clinical pathology) during the first phase. No bird received more than a single dose of diclofenac during the study.
Monitoring: Animals were monitored every 2 hr for the first day, and thereafter, twice daily until 3 days postdosing for any clinical signs of toxicity. Blood samples were collected in serum tubes (Vacuette, Greiner Bio-One International AG, Kremsmuenster, Austria) for clinical chemistry or in heparin tubes (Vacuette) for diclofenac analysis before dosing and at 2, 12, 24, and 48 hr postdosing. Birds were sequentially bled so that the ethical blood volume (,1% of body weight) was not exceeded. Clinical pathology parameters evaluated were sodium (Na + ; mmol/l), potassium (K + ; mmol/l), and calcium (Ca 2+ ; mmol/l) using a RAPIDLab 34E blood gas analyzer (Chiron Diagnostics, Bayer, Johannesburg, South Africa) and uric acid (UA; U/l), alanine aminotransferase (ALT; U/l), creatine kinase (CK; U/l), and albumin (ALB; g/dl) using a Nexet Chemistry Analyzer (Alfa Wassermann, Bayer). Significant differences in changes in clinical pathology parameters were tested using a univariate analysis of variance (SPSS ver. 19, Chicago, Illinois, USA), with dose and phase used as factors.
Three days after the second phase was completed, birds were euthanized by intravenous pentobarbitone overdose and subjected to full necropsy. Liver and kidney samples were collected and frozen for diclofenac residue analysis.
Drug analysis: Tissue and plasma samples (0.5 g and 0.3 ml, respectively) were homogenized in 2 ml of acetonitrile (high performance liquid chromatography [HPLC] grade; Sigma-Aldrich, Gillingham, UK) and centrifuged at 1,000 3 G for 10 min to pellet debris. The supernatant was filtered through a 0.2-mm disposable filter unit (13-mm nylon Puradisc; Whatman, Chalfont St. Giles, UK) into a 2-ml crimp-top HPLC vial (Agilent, Stockport, UK). Diclofenac was separated and quantified by HPLC with electrospray ionization mass spectrometry detection (Agilent) 1100 series equipped with a Waters (Elstree, UK) Xterra MS C18 column and equivalent guard. Diclofenac standard (Sigma-Aldrich; D6899) was dissolved into 1:1 (v/v) acetonitrile:Milli-Q (Millipore UK, Ltd., Durham, UK) water at a 50 mg/l concentration. Calibration standards were then created by dilution of this stock standard in 100% acetonitrile to create a calibration range between 5 and 1,000 mg/l. The calibration was linear across this range with an r 2 value .0.99. Samples and standards (20 ml) were subjected to a binary gradient elution profile, which consisted of 0.1% acetic acid (Sigma-Aldrich) in water (solution A) and in 100% acetonitrile (solution B): starting conditions were 75% A to 25% B for 0.1 min, then a 15-min linear gradient was used from 75%-A:25%-B to 5%-A:95%-B, followed by a 5-min column-wash step using 5%-A:95%-B, and finally a 10-min re-equilibration step with 75%-A:25%-B. Flow rate was 0.7 ml/min, and the column temperature was held at 40 C. The mass spectrometer (Agilent; 1946D) was equipped with an electrospray ionization source, and mass spectra were acquired in the negative ion mode. The mass spectrometer selectively monitored ions 294 and 296 m/z, and 294 m/z (the deprotonated molecular mass) was used to quantify diclofenac residues. The mean diclofenac recovery was 96% in spiked crow plasma and 81% from bovine liver, and the limit of quantification for the method was 10 mg/ l in plasma ).
Pharmacokinetic analysis: Due to the paucity of samples collected as a result of the small size of the Pied Crow (6400 g), complete pharmacokinetic profiles were not obtained. Hence, to obtain an estimate of the average pharmacokinetics of diclofenac in the Pied Crow, the samples collected from individual animals per dose were subjected to naïve average pooling, as described in population pharmacokinetics (Sheiner and Beal, 1981) . The single resultant profile was then evaluated using standard equations and a noncompartmental model. To allow comparisons with other bird species, the noncompartmental equations were also fitted to previously published data (Rattner et al., 2008) for Turkey Vultures (Cathartes aura; n54) dosed at either 8 or 25 mg/kg body weight and to sparse data previously presented for a chicken that died when dosed at 5 mg/kg (intramuscular administration; Naidoo et al., 2007; Rattner et al., 2008) .
In vitro toxicity assay
Consumables: Collagenase, diclofenac, Dulbecco's modified Eagle's medium (DMEM), dichlorofluorescein diacetate (DCFH-DA), phosphate-buffered saline (PBS), fetal calf serum (FCS), penicillin G, streptomycin, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) were all purchased from Sigma South Africa (Johannesburg); culture plates were purchased from NUNC, South Africa (Sandton) and MatrigelH was purchased from the Scientific Group, South Africa (Johannesburg).
Organ harvesting and culture: Three adult crows were caught and immediately euthanized using the procedures described above without administering any treatment or diclofenac. Each crow contributed to a replicate, which was undertaken, 1/wk for 3 wk. Following euthanasia, the kidneys and liver were immediately removed and placed on ice. The organs were subsequently used to ascertain the renal tubular epithelial and hepatic cell sensitivity to diclofenac. Kidney tissue was minced with a scalpel blade and incubated overnight in DMEM with 0.2 mg/ml of collagenase at 37 C (Freshney, 1987) . Cell homogenates were then passed through a 250-and 38-mm filter to isolate the renal tubular epithelial (RTE) cells. The cells were washed three times with PBS buffer by centrifugation at 200 3 G and resuspended in DMEM supplemented with 10% FCS, streptomycin (50 IU/ml), and penicillin G (50 IU/ml). The RTE cell suspensions (200 ml at 10 5 cells/ml) were seeded into 96-well plates (Lu et al., 2004) and given 48 hr at 37 C in 5% CO 2 to establish before incubation with diclofenac (at 80, 40, 20, and 10 mM concentrations) for an additional 48 hr in the presence or absence of uric acid (0.18 mM). Cultures were then incubated with 0.44 mM MTT for 5 hr to assess cell viability (Gerlier and Thomasset, 1986) . The degree of formazan formation was determined on a Varian spectrophotometer (Varian Medical Systems, Inc., Palo Alto, California, USA) at 570 nm (with a 1-cm path length). Cell survival was evaluated as a percentage of viable cells in treated versus untreated control wells on the same plate (% cell viability). The amount of reactive oxygen species (ROS) present was determined in a similar manner, except cultures were incubated with DCFH-DA dye for 30 min, and readings were taken at 504 nm (Gomez-Lechon et al., 2003; Somogyi et al., 2007) .
Whole livers were perfused with saline and then with collagenase (0.2 mg/ml) via a hepatic vein until the hepatic architecture became disaggregated. The hepatocytes were then collected by incising the intact liver capsule. Isolated cells were washed three times by centrifugation at 200 3 G with PBS buffer and resuspended in DMEM supplemented with 10% FCS, streptomycin (50 IU/ ml) and penicillin G (50 IU/ml). The hepatocyte (1 ml; 10 5 cells/ml) suspensions were then seeded into 96-well plates precoated with Matrigel (200 ml; Scientific Group). The 96-well plates were given 48 hr to establish before incubation with diclofenac in the absence or presence of uric acid as above. The ROS and percentage of cell viability were determined the same way as they were for the RTE cells.
RESULTS
No signs of overt toxicity were observed, and no gross lesions were seen in any birds. Clinical pathology parameters were not significantly different between treated and control birds.
Organ and plasma samples were analyzed for their residual concentration of diclofenac. No drug was detectable in the tissues of any of the crows dosed at 0.8 mg/ kg or 10 mg/kg. Likewise, no drug residues were detected in the 48-hr plasma samples (n52) following the 10 mg/kg dose, but crows (n52) sampled at 4 and 12 hr had very low plasma concentrations of, on average, 0.1 mg/ml and 0.01 mg/ml, respectively. The estimated pharmacokinetic parameters based on naïve dosed pooling are given in Table 1 . The profile was characterized by a short half-life of elimination (2.33 hr) and a small, estimated area under the curve (0.05 mg/ml/hr). In addition, the drug was characterized by an extremely large volume of distribution (58.35 l/kg).
To better understand the absence of toxicity, we evaluated the direct effects of diclofenac on liver and renal tubular cell cultures (Fig. 1) . The RTE cell cultures showed very low levels of toxicity (.80% cell viability) when exposed to diclofenac in either the presence or absence of uric acid. In kidney, the toxicity was not dose dependent; in liver, diclofenac produced a dose-related effect in the presence of uric acid, but a nondosedependent effect in the absence of uric acid. As in the kidneys, the evident toxicity was very low. No increases in percentage of ROS production were observed in any of the experimental wells. However, the dose-responsive toxicity for diclofenaconly hepatocytes (in the absence of uric acid) corresponded with increasing ROS production, which was ameliorated by the addition of uric acid (Table 2 ). In contrast, the RTE cultures showed no increase in ROS production following treatment (Table 2) .
DISCUSSION
The lack of toxicity at both low and higher doses was unexpected. Reported parameters (i.e., UA, urea, ALP, and K + ), which were all significantly altered by diclofenac toxicity in Gyps spp. vultures, remained unchanged in crows. Likewise, we observed no evidence of toxicity on necropsy performed 48 hr after the 10 mg/ kg dose (i.e., the study was designed to pick up acute changes if they were present). These findings were in marked contrast to vultures, where severe clinical signs of depression were evident 24 hr postexposure and worsened until the birds entered a coma and died around 48 hr postexposure. In addition, these vultures always demonstrated massive increases in serum uric acid concentrations with concurrent visceral gout evident on necropsy. Our findings were, however, very similar to those previously reported for Turkey Vultures (Rattner et al., 2008) , suggesting that toxicity is not linked to consumption of carrion (and consequential to high uric acid generation) but to other biochemical factors.
Although it was not possible to obtain full pharmacokinetic profiles for individual birds, parameters were estimated using naïve dose pooling and equations designed for therapeutic dose monitoring (Table 1) . Although these parameters are, by nature, likely to be overestimates, they still provide important indications of metabolic capacity and the total extent of exposure and are, therefore, used in an attempt to explain the lack of toxicity, instead of describing the pharmacokinetics of diclofenac in the crow. In the Pied Crow, diclofenac was characterized by a rapid half-life elimination, which was much shorter than that observed in Turkey Vultures and Gyps spp. (Swan et al., 2006b; Rattner et al., 2008; Naidoo et al., 2009 ). The half-life elimination was, however, twice that reported for the Domestic Chicken (as evaluated in a full pharmacokinetic study), which also survived with no signs of toxicity. The crow profile was also characterized by very low plasma diclofenac concentrations and, in turn, a low level of exposure (0.54 mg/ml per hour), indicating that overall exposure in the systemic circulation was low (reflected by the large volumetric distribution [V z ]). Although parenteral administration is required to provide a better description of the pharmacokinetics, low systemic circulation in conjunction with a large V z suggests presystemic elimination plays a major role in the oral bioavailability of diclofenac in Pied Crows.
The pharmacokinetic parameters (in comparison to other avian species) demonstrated a clear relationship between half-life and death/toxicity (Table 3; Swan et al., 2006b; Naidoo et al., 2007 Naidoo et al., , 2009 Rattner et al., 2008) . In all cases where plasma concentration data were available, birds tended to die when half-life elimination was above 12 hr. However, when the half-life was ,7 hr, animals survived. This observation was marked in the chicken, where a low dose resulted in no mortality and showed a half-life of 1 hr, whereas, at a 5 mg/kg dose, the one bird treated died and displayed a half-life profile of 14 hr. This suggests that toxicity is related to zero-order metabolism. A similar finding was reported in a pharmacokinetic study of ketoprofen in Cape Griffon Vultures (Gyps coprotheres), where toxicity occurred at higher doses, when half-life elimination also indicated zero-order metabolism (Naidoo et al., 2010a) . Zero-order pharmacokinetics implies that the liver (or a related organ of metabolism) fails to adequately metabolize the drug in a timely manner. Because of this limitation, the drug accumulates within the body until toxicity occurs.
To determine whether diclofenac toxicity was related to half-life elimination, and not to cellular sensitivity (as seen in Gyps vultures), isolated renal tubular and hepatic cells were exposed to four concentrations of diclofenac for 48 hr. The long period of exposure was used to simulate an extremely long mean residence time in vivo, which corresponded to the maximum incubation period observed in other studies (Ng et al., 2008; Naidoo et al., 2009 ). In addition, the concentrations used were significantly larger than those actual concentrations measured in the crow at 4 hr in the pharmacokinetic profile. In hepatocytes, toxic effects were minimal and cell viability fluctuated between 80 and 100%. A linear toxic-response relationship was also present in the diclofenac group in the presence of uric acid, which corresponded with increased ROS production, as seen in chicken RTE cells (Naidoo et al., 2009) .
As with the hepatocytes, RTE cells were also minimally affected by the presence of diclofenac (.80% cell viability observed), with the evident toxicity being unrelated to ROS production. The low level of toxicity was similar to that reported by Ng et al. (2008) , where mammalian cells were also minimally sensitive to the toxic effects of diclofenac. However, Pied Crow cells showed markedly different results from those of chickens, where cell viability was ,20% following a similar period of incubation (Naidoo and Swan, 2009 ). This indicates that the RTE cells of the Pied Crow are even more tolerant to diclofenac and that rapid hepatic metabolism is not the only reason why crows are insensitive to diclofenac. It may even be possible that the CYP2c9 (cytochrome P450 2C9) concentrations within the crow RTE cells are naturally higher, thereby offering a greater degree of protection; the rapid metabolism may be due to a combined effect caused by liver and extrahepatic kidney metabolism.
In summary, if we consider that slow diclofenac metabolism in bird species is linked to toxicity, we suggest that rapid metabolism (and thus low systemic bioavailability) may indicate tolerance to diclofenac (as noted in Pied Crows and Turkey Vultures). In addition, toxicity seems to be clearly related to the sensitivity of the RTE cells to diclofenac. This is demonstrated by the minimal toxicity in primary crow RTE cells, as opposed to chicken RTE cells, despite exposure at equal concentrations. The Pied Crow is, therefore, not a suitable model for the testing of other nonsteroidal Values for all species, except G. domesticus at 0.8 mg/kg oral route, were estimated using equations described for noncompartmental modeling.
anti-inflammatory drugs for overt toxic effect.
